Flouting all requirements, Russia plans to launch early COVID-19 vaccine knowledge

An older man in a suit speaks into an array of microphones.

Enlarge / MOSCOW, RUSSIA – AUGUST 14, 2020: Alexander Gintsburg, director of the Gamaleya Scientific Analysis Institute of Epidemiology and Microbiology of the Russian Healthcare Ministry that produces a COVID-19 vaccine. (credit score: Getty | Vyacheslav Prokofyev)

A prime Russian researcher behind the Sputnik V coronavirus vaccine defended utilizing the vaccine earlier than testing was full and mentioned he plans to launch medical trial knowledge early—so early, in reality, the information is unlikely to be interpretable.

Alexander Gintsburg, head of the Gamaleya Institute that developed Sputnik V, laid out his ideas on the vaccine and the pandemic in an interview with Reuters printed Tuesday.

“Persons are dying identical to throughout a struggle,” Gintsburg mentioned as he sat in his wood-paneled workplace in Moscow, holding a crystal mannequin of a coronavirus. “However this fast-tracked tempo isn’t synonymous—as some media have prompt—with corners being minimize. No means.”

Learn 11 remaining paragraphs | Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *